Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19

Detalles Bibliográficos
Autores principales: Nakamura, Hideta, Kinjo, Takeshi, Arakaki, Wakako, Miyagi, Kazuya, Tateyama, Masao, Fujita, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399594/
https://www.ncbi.nlm.nih.gov/pubmed/32753065
http://dx.doi.org/10.1186/s13054-020-03209-6
_version_ 1783566170941554688
author Nakamura, Hideta
Kinjo, Takeshi
Arakaki, Wakako
Miyagi, Kazuya
Tateyama, Masao
Fujita, Jiro
author_facet Nakamura, Hideta
Kinjo, Takeshi
Arakaki, Wakako
Miyagi, Kazuya
Tateyama, Masao
Fujita, Jiro
author_sort Nakamura, Hideta
collection PubMed
description
format Online
Article
Text
id pubmed-7399594
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73995942020-08-04 Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19 Nakamura, Hideta Kinjo, Takeshi Arakaki, Wakako Miyagi, Kazuya Tateyama, Masao Fujita, Jiro Crit Care Research Letter BioMed Central 2020-08-04 /pmc/articles/PMC7399594/ /pubmed/32753065 http://dx.doi.org/10.1186/s13054-020-03209-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Letter
Nakamura, Hideta
Kinjo, Takeshi
Arakaki, Wakako
Miyagi, Kazuya
Tateyama, Masao
Fujita, Jiro
Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19
title Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19
title_full Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19
title_fullStr Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19
title_full_unstemmed Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19
title_short Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19
title_sort serum levels of receptor-interacting protein kinase-3 in patients with covid-19
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399594/
https://www.ncbi.nlm.nih.gov/pubmed/32753065
http://dx.doi.org/10.1186/s13054-020-03209-6
work_keys_str_mv AT nakamurahideta serumlevelsofreceptorinteractingproteinkinase3inpatientswithcovid19
AT kinjotakeshi serumlevelsofreceptorinteractingproteinkinase3inpatientswithcovid19
AT arakakiwakako serumlevelsofreceptorinteractingproteinkinase3inpatientswithcovid19
AT miyagikazuya serumlevelsofreceptorinteractingproteinkinase3inpatientswithcovid19
AT tateyamamasao serumlevelsofreceptorinteractingproteinkinase3inpatientswithcovid19
AT fujitajiro serumlevelsofreceptorinteractingproteinkinase3inpatientswithcovid19

Ejemplares similares